Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 3751-3757, November 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biedler, J. L.
Right arrow Articles by Freedman, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biedler, J. L.
Right arrow Articles by Freedman, L. S.

Multiple Neurotransmitter Synthesis by Human Neuroblastoma Cell Lines and Clones

June L. Biedler1, Suzanne Roffler-Tarlov2, Melitta Schachner3 and Lewis S. Freedman

Laboratory of Cellular and Biochemical Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [J. L. B.]; Department of Neuroscience, Children's Hospital Medical Center, Boston, Massachusetts 02115 [S. R.-T., M. S.]; and Department of Neurology, Division of Behavioral Neurology, New York University Medical Center, New York, New York 10016 [L. S. F.]

Continuously cultured human neuroblastoma cell lines SK-N-SH, SK-N-BE(1), SK-N-BE(2), and SK-N-MC, as well as several clonally derived sublines, were assessed for their neurotransmitter characteristics. Two different methods were used: measurement of cholinergic and adrenergic enzyme activities and detection of neurotransmitters synthesized from radioactive precursors. Dopamine-ß-hydroxylase (EC 1.14.2.1), choline acetyltransferase (EC 2.3.1.6), acetylcholinesterase (EC 3.1.1.7), and butyrylcholinesterase (EC 3.1.1.8) levels were compared to those of various normal and neuronal cell controls. The capacity of neuroblastoma lines and clones to convert radioactive tyrosine, choline, and glutamate to transmitter products was determined. SK-N-SH, SK-N-BE(1), and SK-N-BE(2) cells had moderately high levels of dopamine-ß-hydroxylase activity. Whereas neuroblast-like clones of SK-N-SH had similar levels of this enzyme, epithelial-like clones had no detectable activity. SK-N-BE(2) cells showed the greatest capacity to convert tyrosine to dopamine. Although the SK-N-SH line itself was not tested, both neuroblast and epithelial-like clones, shown by karyotype analysis to have a common cell precursor, converted tyrosine to dopamine. In contrast, the SK-N-MC line and its clones appeared devoid of adrenergic properties. All cells tested except human fibroblast-like cells of normal origin were able to convert radioactive choline to acetylcholine. While all the cell lines had measurable choline acetyltransferase activity, levels were substantially higher (at least 4- to 12-fold) for SK-N-MC cells and its clonally derived subline MC-IXC. All cells tested converted glutamate to {gamma}-aminobutyric acid. Results indicate that these human neuroblastoma cell lines have predominating neurotransmitter characteristics that are sometimes, but not always, expressed in clones derived from them. Since the SK-N-BE(1) and SK-N-BE(2) lines were isolated 5 months apart from the same patient and have similar activity levels of dopamine-ß-hydroxylase, these characteristics may be stable and representative of the tumor cells in vivo. Furthermore, results obtained by the two different methodological approaches suggest that, whereas SK-N-MC cells show cholinergic and not adrenergic traits, SK-N-SH and possibly SK-N-BE(2) may be multipotential with regard to neuronal enzyme expression.

1 Recipient of NIH Grants CA-08748 and CA-18856. To whom requests for reprints should be addressed.

2 Recipient of NIH Grants NS-09704 and NS-12200.

3 Recipient of NIH Grant NS-12659-O1A1. Present address: Department of Neurobiology, Heidelberg University, Im Neuenheimer Feld 347, 69 Heidelberg, GFR.

Received 2/16/78. Accepted 8/18/78.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. A. Merrill, L. A. Plum, M. E. Kaiser, and M. Clagett-Dame
A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos
PNAS, March 19, 2002; 99(6): 3422 - 3427.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.